Vice President, Strategic Customer Group, Commercial

Position: Vice President, Strategic Customer Group, Commercial

Philadelphia, PA (Hybrid)

Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA™ platform encompasses two complementary strategies which aim to advance the discovery and development of engineered T cell therapies with the potential to become deep and durable, perhaps curative, treatments for a broad range of autoimmune diseases. The lead CARTA (Chimeric Antigen Receptor T cells for Autoimmunity) strategy is prioritizing the development of rese-cel, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy. Rese-cel is currently being evaluated in the RESET™ (REstoring SElf-Tolerance) clinical development program spanning multiple therapeutic areas, including rheumatology, neurology and dermatology. The company recently presented final phase 1/2 data for rese-cel in myositis and expects to initiate the pivotal myositis trial this year. Cabaletta Bio's headquarters and labs are based in Philadelphia, PA. For more information, please visit and connect with us on LinkedIn.

At Cabaletta, we are driven by the shared mission of developing cures, where a patient's own cells are used to fight disease. We are building a culture grounded in the knowledge that successful cures can be achieved for patients if every member of the Cabaletta is focused on the success of the team. To nurture this, we make an active commitment to the well-being and continuous growth of each employee who joins the team. In this way, we are not only working to improve the lives of patients, but of everyone involved. And we're proud that for 3 years in a row, we've been nationally recognized by Great Place to Work and Fortune as one of the Top 10 Best Small/Medium Workplaces in Biopharma!

About the Position

Reporting to the Chief Commercial Officer, the Vice President (VP), Strategic Customer Group is responsible for leading all customer-facing market access, trade, and account management activities to ensure successful coverage, reimbursement, and delivery of Cabaletta Bio's CAR-T therapies. This role serves as the primary external interface with key stakeholders and is accountable for execution of contracting strategies and development of long-term partnerships across the healthcare ecosystem.

Key Responsibilities

Customer Leadership & Stakeholder Engagement

• Own all customer-facing interactions with key stakeholders, including private payers, hospital administrators, and integrated delivery networks.
• Build and maintain executive-level relationships to support access and adoption.

Contract Development & Negotiation

• Lead development, negotiation, and execution of contracts with payers, providers, and health systems.
• Ensure alignment with pricing, access strategy, and compliance requirements.

Trade & Distribution Strategy

• Oversee specialty pharmacy strategy and trade management to support cell therapy delivery.
• Ensure coordination across distribution channels, providers, and payers.

Group Purchasing Organization (GPO) Engagement

• Lead strategy and relationships with GPOs and hospital purchasing entities.

Provider & Site-of-Care Enablement

• Partner with hospital administrators and treatment centers to ensure operational readiness and patient access.

Advisory Boards & Insights Generation

• Co-lead payer and hospital advisory boards to gather insights and inform strategy.

Pipeline & Business Development Support

• Partner with New Product Planning (NPP) on future indications and business development opportunities by bringing forward customer insights.

Qualifications

• Advanced degree preferred (MBA, PharmD, PhD, or equivalent).
• 15+ years of experience in market access, payer engagement, or strategic account management.
• Proven experience leading contracting and negotiations across payers and providers.
• Deep expertise in specialty pharmacy, trade, and/or buy-and-bill models.
• Experience in cell/gene therapy or complex specialty launches strongly preferred.
• Exceptional relationship-building, leadership, and negotiation skills.

Our name - Cabaletta - is derived from the operatic term that represents a rapid, repetitive, and technically challenging section of an operatic aria, where the second act is designed to showcase the skills of the lead singer. Analogously, Cabaletta Bio strives to achieve rapid and repetitive product development, building on our indication prioritization and biologic platform that targets the driver of specific autoimmune diseases without the need for long-term immunosuppression.

For more information, please visit

Our most important asset is our people, and we offer competitive benefits, PTO, and stock option plans.

Cabaletta Bio is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law.